By Susan Crowley
Public policy activities should be a distinct, mission critical function for Big Pharma — our business depends increasingly on government as a key customer. However, as companies confront the necessity to plump up the bottom line as patents expire, staffing of non-line functions has taken a big hit, with policy advocacy work emerging [...]
Good Policy: The Victim of 'Good Works'?